Chapter 20 Movement Disorders Flashcards
Movement Disorders Definition – A group of CNS degenerative diseases associated with involuntary movements or abnormalities of skeletal muscle tone and posture. They can be broadly classified as ___________ (too little) or ___________ (too much) movement disorders.
Movement Disorders Definition – A group of CNS degenerative diseases associated with involuntary movements or abnormalities of skeletal muscle tone and posture. They can be broadly classified as hypokinetic (too little) or hyperkinetic (too much) movement disorders.
Pathophysiology of Parkinson’s Disease (PD; Hypokinetic Movement Disorder) – The predominant area of involvement is ___________ ___________, which are primarily ___________ in function. Affects the ___________-producing cells (substantia nigra and ___________ ___________) of basal ganglia, resulting in degeneration of nigrostriatal pathway and thereby causing decreased dopamine in the corpus striatum. This results in loss of inhibitory input to the cholinergic system, allowing excessive excitatory output.
Pathophysiology of Parkinson’s Disease (PD; Hypokinetic Movement Disorder) – The predominant area of involvement is basal ganglia, which are primarily inhibitory in function. Affects the dopamine-producing cells (substantia nigra and locus ceruleus) of basal ganglia, resulting in degeneration of nigrostriatal pathway and thereby causing decreased dopamine in the corpus striatum. This results in loss of inhibitory input to the cholinergic system, allowing excessive excitatory output.
Parkinson’s Disease Etiology – Unknown. The most common movement disorder is Parkinson’s disease, affecting 1% of the population over 50 years of age. Incidence is 20/100,000 per year. Male:female ratio is 3:2. Associated with ___________ and ___________ use; 5% to 10% is hereditary (five genes identified so far).
Parkinson’s Disease Etiology – Unknown. The most common movement disorder is Parkinson’s disease, affecting 1% of the population over 50 years of age. Incidence is 20/100,000 per year. Male:female ratio is 3:2. Associated with pesticide and herbicide use; 5% to 10% is hereditary (five genes identified so far).
Parkinson’s Disease Clinical Presentation
– The most common initial symptom is ___________ tremor (___________-rolling tremor) in the hands.
– Characterized by a triad of ___________ tremor, ___________, and muscle ___________.
– Features of advanced disease include ___________ facies, ___________ gait (shuffling), and postural instability due to loss of postural reflexes, resulting in fall to side or backward.
– ___________ phenomenon (transient inability to perform or restart certain tasks).
– ___________.
– ___________ (40%).
Parkinson’s Disease Clinical Presentation
– The most common initial symptom is resting tremor (pill-rolling tremor) in the hands.
– Characterized by a triad of resting tremor, bradykinesia, and muscle rigidity.
– Features of advanced disease include masked facies, festinating gait (shuffling), and postural instability due to loss of postural reflexes, resulting in fall to side or backward.
– Freezing phenomenon (transient inability to perform or restart certain tasks).
– Depression.
– Dementia (40%).
Parkinson’s Disease Treatment – ___________ or ___________.
Parkinson’s Disease Treatment – Medical or surgical.
Parkinson’s Disease
The goal of medical treatment is to increase ___________ action and decrease ___________ effect. A guiding principle is to start treatment when symptoms interfere with performing ADLs.
Parkinson’s Disease
The goal of medical treatment is to increase dopamine action and decrease cholinergic effect. A guiding principle is to start treatment when symptoms interfere with performing ADLs.
Parkinson’s Disease
L-Dopa: Precursor of ___________. Given with ___________ (a dopa decarboxylase inhibitor), which prevents systemic metabolism of L-dopa (example: Sinemet).
Parkinson’s Disease
L-Dopa: Precursor of dopamine. Given with carbidopa (a dopa decarboxylase inhibitor), which prevents systemic metabolism of L-dopa (example: Sinemet).
Parkinson’s Disease Dopaminergic agonists:
Ergot derivatives – ___________ (stimulates D2 receptors) and pergolide (stimulates D1 and D2 receptors).
Nonergot derivatives – ropinirole (Requip) and ___________ (Mirapex).
Parkinson’s Disease Dopaminergic agonists:
Ergot derivatives – bromocriptine (stimulates D2 receptors) and pergolide (stimulates D1 and D2 receptors).
Nonergot derivatives – ropinirole (Requip) and pramipexole (Mirapex).
Parkinson’s Disease
___________ – an antiviral that potentiates release of endogenous dopamine and has mild anticholinergic activity.
Parkinson’s Disease
Amantadine – an antiviral that potentiates release of endogenous dopamine and has mild anticholinergic activity.
Parkinson’s Disease
Anticholinergics – effective in ___________ ___________. Includes trihexiphenidyl (Artane), benztropine (Cogentin), procyclidine, and orphenadrine.
Parkinson’s Disease
Anticholinergics – effective in relieving tremor. Includes trihexiphenidyl (Artane), benztropine (Cogentin), procyclidine, and orphenadrine.
Parkinson’s Disease
___________ of dopamine metabolism – inhibits ___________ ___________ (MAO)-B that is predominant in the striatum.
Selegiline – decreases oxidative damage in substantia nigra and slows disease progression.
Tolcapone – catechol-O-methyltransferase inhibitor, inhibits metabolism of dopamine in the liver, GI tract, and other organs.
Parkinson’s Disease
Inhibitors of dopamine metabolism – inhibits monoamine oxidase (MAO)-B that is predominant in the striatum.
Selegiline – decreases oxidative damage in substantia nigra and slows disease progression.
Tolcapone – catechol-O-methyltransferase inhibitor, inhibits metabolism of dopamine in the liver, GI tract, and other organs.
Parkinson’s Disease
Surgical treatment is indicated in patients with advanced disease in whom medical treatment is ineffective or poorly tolerated. Mostly effective in relief of tremor. Complications include brain ___________, infection, and device failure.
Destructive surgery – ___________ or ___________.
Parkinson’s Disease
Surgical treatment is indicated in patients with advanced disease in whom medical treatment is ineffective or poorly tolerated. Mostly effective in relief of tremor. Complications include brain hemorrhage, infection, and device failure.
Destructive surgery – thalamotomy or pallidotomy.
Parkinson’s Disease
Deep brain stimulator – electrode placed into ventral intermediate nucleus of the ___________.
Parkinson’s Disease
Deep brain stimulator – electrode placed into ventral intermediate nucleus of the thalamus.
Parkinson’s Disease Causes for Disability
Social ___________.
Manual ___________ (inability to perform ADLs such as dressing, cutting food, writing, and fine motor skills).
___________ posture, resulting in loss of balance and increased risk of falls.
___________ of gait, resulting in retropulsion (staggering backward) or propulsion (stumble forward).
Speech impairment.
___________, resulting in silent aspiration.
___________ due to decreased frequency of spontaneous swallowing.
Parkinson’s Disease Causes for Disability
Social isolation.
Manual dexterity (inability to perform ADLs such as dressing, cutting food, writing, and fine motor skills).
Stooped posture, resulting in loss of balance and increased risk of falls.
Slowness of gait, resulting in retropulsion (staggering backward) or propulsion (stumble forward).
Speech impairment.
Dysphagia, resulting in silent aspiration.
Drooling due to decreased frequency of spontaneous swallowing.
Parkinson’s Disease Rationale for Rehabilitation – Functionally based, i.e., objectively assessed using unified PD rating scale (UPDRS), which includes assessment of walking ___________, ___________, backward and forward stepping, ability to navigate obstacles, fine motor tasks, equilibrium, and simultaneous and sequential tasks.
Parkinson’s Disease Rationale for Rehabilitation – Functionally based, i.e., objectively assessed using unified PD rating scale (UPDRS), which includes assessment of walking speed, distance, backward and forward stepping, ability to navigate obstacles, fine motor tasks, equilibrium, and simultaneous and sequential tasks.